A traceless reversible polymeric colistin prodrug to combat multidrug-resistant (MDR) gram-negative bacteria
Chongyu Zhu, Elena K Schneider, Jiping Wang, Kristian Kempe, Paul Wilson, Tony Velkov, Jian Li, Thomas P Davis, Michael R Whittaker, David M Haddleton
Journal of Controlled Release | ELSEVIER SCIENCE BV | Published : 2017
Awarded by EPSRC
Awarded by Leverhulme Trust
Awarded by Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology
Awarded by NHMRC-ARC Dementia Research Development Fellowship
The authors thank Dr. Lijiang Song for the help on MALDI-ToF MS analysis and gratefully acknowledge Heidi Yu and Jesmin Akter for the help and discussion on the microbiological test. We gratefully acknowledge the financial support from the EPSRC (1367109, C. Z.), Leverhulme Trust (ECF/2015-075, P. W.) and Australian Research Council Centre of Excellence in Convergent Bio-Nano Science and Technology (project number CE140100036). K.K. gratefully acknowledges the award of an NHMRC-ARC Dementia Research Development Fellowship (APP1109945).